Prognostic Implication of Diagnostic Confidence Level in Patients with Fibrotic Hypersensitivity Pneumonitis

被引:6
|
作者
Kang, Jieun [1 ,2 ]
Kim, Yeon Joo [1 ]
Choe, Jooae [3 ]
Chae, Eun Jin [3 ]
Song, Joon Seon [4 ]
Song, Jin Woo [1 ]
机构
[1] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pulm & Crit Care Med, Seoul, South Korea
[2] Inje Univ, Coll Med, Ilsan Paik Hosp, Div Pulm & Crit Care Med,Dept Internal Med, Goyang, South Korea
[3] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Radiol, Seoul, South Korea
[4] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Pathol, Seoul, South Korea
基金
新加坡国家研究基金会;
关键词
Hypersensitivity pneumonitis; Mortality; Prediction; Prognosis; IDIOPATHIC PULMONARY-FIBROSIS; PREDICTS SURVIVAL; LUNG-DISEASE; STANDARDIZATION; CLASSIFICATION;
D O I
10.1159/000517921
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Hypersensitivity pneumonitis (HP) has various clinical courses and outcomes, but the prognostic factors are not well-defined. Vasakova et al. [Am J Respir Crit Care Med. 2017 Sep;196(6):680-9] have proposed a diagnostic algorithm that categorized suspected patients according to the level of confidence in the diagnosis. This study aimed to investigate whether the confidence level of clinical diagnosis has prognostic implication in patients with fibrotic HP. Methods: This study included 101 biopsy-proven fibrotic HP patients diagnosed between 2002 and 2017. The patients were retrospectively classified into confident, probable, possible, and unlikely chronic HP, according to the confidence level in the diagnostic criteria/algorithm. The survival and forced vital capacity (FVC) changes were compared between the groups. Risk factors for mortality were analysed using a Cox proportional hazard model. Results: The median follow-up duration was 67.6 months. The mean age was 60.4 years, and percentages of women were 60.4%. When classified based on the diagnostic criteria/algorithm, possible HP was the most common (51.5%), followed by probable (26.7%), confident (9.9%), and unlikely HP (6.9%). Distinctive survival curves were found according to the diagnostic confidence level, showing the worst outcome in unlikely chronic HP (median survival, 30.2 months). In a multivariable Cox analysis, unlikely HP was a significant predictor of poor survival (hazard ratio, 4.652; 95% confidence interval, 1.231-17.586; p = 0.023), after adjustment for age, body mass index, FVC, and diffusing capacity. Conclusions: The diagnostic confidence level may predict clinical outcomes in patients with HP. Unlikely HP was shown to have a significantly poorer survival than other diagnostic confidence levels.
引用
收藏
页码:940 / 948
页数:9
相关论文
共 50 条
  • [21] Diagnosis of Fibrotic Hypersensitivity Pneumonitis: Is There a Role for Biomarkers?
    Pereira, Joao O.
    Fernandes, Vania
    Alfaro, Tiago M.
    Freitas, Sara
    Cordeiro, Carlos Robalo
    LIFE-BASEL, 2023, 13 (02):
  • [22] Clinical characteristics of hypersensitivity pneumonitis: non-fibrotic and fibrotic subtypes
    Chen, Xueying
    Yang, Xiaoyan
    Ren, Yanhong
    Xie, Bingbing
    Xie, Sheng
    Zhao, Ling
    Wang, Shiyao
    Geng, Jing
    Jiang, Dingyuan
    Luo, Sa
    He, Jiarui
    Shu, Shi
    Hu, Yinan
    Zhu, Lili
    Li, Zhen
    Zhang, Xinran
    Liu, Min
    Dai, Huaping
    CHINESE MEDICAL JOURNAL, 2023, 136 (23) : 2839 - 2846
  • [23] Prognostic factors in Korean patients with chronic hypersensitivity pneumonitis
    Kim, Yeon Joo
    Choe, Jooae
    Chae, Eun Jin
    Song, Joon Seon
    Kim, Dong Soon
    Song, Jin Woo
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [24] Clinical characteristics of hypersensitivity pneumonitis: non-fibrotic and fibrotic subtypes
    Chen Xueying
    Yang Xiaoyan
    Ren Yanhong
    Xie Bingbing
    Xie Sheng
    Zhao Ling
    Wang Shiyao
    Geng Jing
    Jiang Dingyuan
    Luo Sa
    He Jiarui
    Shu Shi
    Hu Yinan
    Zhu Lili
    Li Zhen
    Zhang Xinran
    Liu Min
    Dai Huaping
    中华医学杂志英文版, 2023, 136 (23)
  • [25] Prognostic factors of progressive fibrotic hypersensitivity pneumonitis: a large, retrospective, multicentre, observational cohort study
    Cano-Jimenez, Esteban
    Villar Gomez, Ana
    Velez Segovia, Eduardo
    Aburto Barrenechea, Myriam
    Sellares Torres, Jacobo
    Francesqui, Joel
    Portillo Carroz, Karina
    Solis Solis, Alan Jhunior
    Acosta Fernandez, Orlando
    Llanos Gonzalez, Ana Belen
    Bordas-Martinez, Jaume
    Cabrera Cesar, Eva
    Balcells Vilarnau, Eva
    Castillo Villegas, Diego
    Reyes Pardessus, Ana
    Gonzalez Fernandez, Coral
    Garcia Moyano, Marta
    Urrutia Gajate, Amaia
    Blanco Hortas, Andres
    Molina-Molina, Maria
    ERJ OPEN RESEARCH, 2024, 10 (01)
  • [26] HYPERSENSITIVITY PNEUMONITIS - A DIAGNOSTIC DILEMMA
    CHIU, A
    PEGRAM, PS
    HAPONIK, EF
    JOURNAL OF THORACIC IMAGING, 1993, 8 (01) : 69 - 78
  • [27] DISCREPANCY BETWEEN TREATMENT AND DIAGNOSTIC CONFIDENCE IN HYPERSENSITIVITY PNEUMONITIS: A CROSS-SECTIONAL STUDY
    Glick, Matthew R.
    Callahan, Sean J.
    Pirozzi, Cheryl S.
    Scholand, Mary Beth
    CHEST, 2024, 166 (04) : 6468A - 6469A
  • [28] Antigen identification and avoidance on outcomes in fibrotic hypersensitivity pneumonitis
    Petnak, Tananchai
    Thongprayoon, Charat
    Baqir, Misbah
    Ryu, Jay H.
    Moua, Teng
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60 (04)
  • [29] Hypersensitivity pneumonitis: Acute, chronic nonfibrotic, and chronic fibrotic
    Inase, Naohiko
    RESPIRATORY INVESTIGATION, 2022, 60 (01) : 1 - 2
  • [30] Acute exacerbation of fibrotic hypersensitivity pneumonitis: incidence and outcomes
    Kang, Jieun
    Kim, Yeon Joo
    Choe, Jooae
    Chae, Eun Jin
    Song, Jin Woo
    RESPIRATORY RESEARCH, 2021, 22 (01)